Frequently Asked Questions

General Queries & Conference Information

Find answers to the most common questions regarding registration, abstract submissions, presentation guidelines, venue details, and participation at Vaccine Discovery & Development 2027.

Q: What are the dates and location of the conference?

Ans: Vaccine Discovery & Development 2027 will be held from May 25–27, 2027 in Valencia, Spain.

Q: How can I submit an abstract for the conference?

Ans: You can submit your abstract through the Abstract Submission page on our website. Complete the required presenter details, select your preferred scientific session, and upload your abstract according to the submission guidelines.

Q: Does submitting an abstract mean I am automatically registered?

Ans: No. Abstract submission and conference registration are separate processes. Once your abstract is accepted, the presenting author must complete the registration process to confirm participation.

Q: What are the available presentation formats?

Ans: Participants may submit their research for Oral Presentation or Poster Presentation. The final presentation format may be determined based on the scientific review and conference program requirements.

Q: Will I receive an official invitation letter for visa processing?

Ans: Official invitation letters can be provided to registered participants who require supporting documentation for their visa application. Please contact the conference secretariat for further assistance.

Q: Who can attend Vaccine Discovery & Development 2027?

Ans: The conference welcomes researchers, scientists, healthcare professionals, vaccine developers, pharmaceutical and biotechnology professionals, academicians, students, and industry experts working in vaccine research and development.

Q: Will accommodation information be provided for attendees?

Ans: Yes. Information regarding recommended accommodation options near the conference venue in Valencia will be shared with registered participants.